$0.6900
0.023.76%
At close: -
$0.6776
-0.01-1.80%
After Hours: Mar 20, 8:50 AM EDT
Comments
Loading...
ABVC BioPharma (ABVC) Forecast
NewsEarningsABVC BioPharma (ABVC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
ABVC BioPharma Stock Price, Quotes and Forecasts | NASDAQ:ABVC | Benzinga
Explore ABVC BioPharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ABVC.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy ABVC BioPharma (ABVC) stock?
You can purchase shares of ABVC BioPharma (NASDAQ:ABVC) through any online brokerage.
Who are ABVC BioPharma (ABVC) competitors?
Other companies in ABVC BioPharma’s space includes: Eterna Therapeutics (NASDAQ:ERNA), HOOKIPA Pharma (NASDAQ:HOOK), Cellectar Biosciences (NASDAQ:CLRB), CARISMA Therapeutics (NASDAQ:CARM) and Imunon (NASDAQ:IMNN).
What is the forecast, or price target, for ABVC BioPharma (ABVC) stock?
There is no analysis for ABVC BioPharma to provide a consensus price target.
What is the current price for ABVC BioPharma (ABVC)?
The stock price for ABVC BioPharma (NASDAQ: ABVC) is $0.6776 last updated March 20, 2025 at 8:50 AM EDT.
Does ABVC BioPharma (ABVC) pay a dividend?
There are no upcoming dividends for ABVC BioPharma.
When is ABVC BioPharma (NASDAQ:ABVC) reporting earnings?
ABVC BioPharma’s Q1 earnings are confirmed for Friday, May 16, 2025.
Is ABVC BioPharma (ABVC) going to split?
There is no upcoming split for ABVC BioPharma.
What sector and industry does ABVC BioPharma (ABVC) operate in?
ABVC BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.